Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.

Guvakova MA, Lee WS, Furstenau DK, Prabakaran I, Li DC, Hung R, Kushnir N.

Biochem J. 2014 Oct 15;463(2):257-70. doi: 10.1042/BJ20131638.

PMID:
25028810
2.

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ.

Jiang Y, Prabakaran I, Wan F, Mitra N, Furstenau DK, Hung RK, Cao S, Zhang PJ, Fraker DL, Guvakova MA.

Biomark Res. 2014 Nov 28;2:22. doi: 10.1186/2050-7771-2-22. eCollection 2014.

3.

Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer.

Prabakaran I, Grau JR, Lewis R, Fraker DL, Guvakova MA.

J Thyroid Res. 2011;2011:979840. doi: 10.4061/2011/979840. Epub 2011 Oct 20.

4.

Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ.

Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA.

Breast Cancer Res Treat. 2011 Sep;129(2):361-72. doi: 10.1007/s10549-010-1227-y. Epub 2010 Oct 26.

PMID:
20976540
5.

Insulin-like growth factors control cell migration in health and disease.

Guvakova MA.

Int J Biochem Cell Biol. 2007;39(5):890-909. Epub 2006 Oct 26. Review.

PMID:
17113337
6.

Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells.

Lynch L, Vodyanik PI, Boettiger D, Guvakova MA.

Mol Biol Cell. 2005 Jan;16(1):51-63. Epub 2004 Oct 27.

8.

Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor.

Guvakova MA, Boettiger D, Adams JC.

Int J Biochem Cell Biol. 2002 Jun;34(6):685-98.

PMID:
11943599
9.

SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility.

Mauro L, Sisci D, Bartucci M, Salerno M, Kim J, Tam T, Guvakova MA, Ando S, Surmacz E.

Exp Cell Res. 1999 Nov 1;252(2):439-48.

PMID:
10527634
11.

Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells.

Salerno M, Sisci D, Mauro L, Guvakova MA, Ando S, Surmacz E.

Int J Cancer. 1999 Apr 12;81(2):299-304.

12.

Type I insulin-like growth factor receptor function in breast cancer.

Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, Sciacca L.

Breast Cancer Res Treat. 1998 Feb;47(3):255-67. Review.

PMID:
9516080
13.

Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.

Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA, Surmacz E.

Int J Cancer. 1997 Sep 4;72(5):828-34.

14.
17.

Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.

Tonkinson JL, Guvakova M, Khaled Z, Lee J, Yakubov L, Marshall WS, Caruthers MH, Stein CA.

Antisense Res Dev. 1994 Winter;4(4):269-78.

PMID:
7537561
18.

High frequency of tumour cell reversion to non-tumorigenic phenotype.

Lavrovsky VA, Guvakova MA, Lavrovsky YV.

Eur J Cancer. 1992;28(1):17-21.

PMID:
1567666
19.

[Isolation from a murine tumor line of clones whose growth in vivo is totally blocked by macrophages].

LavrovskiÄ­ VA, Guvakova MA.

Dokl Akad Nauk SSSR. 1990;310(4):990-2. Russian. No abstract available.

PMID:
2347287
21.

[Enhanced cell lysis by natural effectors--a necessary stage of tumor progression].

LavrovskiÄ­ VA, Iurchenko IuA, Guvakova MA.

Dokl Akad Nauk SSSR. 1986;288(3):760-2. Russian. No abstract available.

PMID:
3720513

Supplemental Content

Loading ...
Support Center